Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Contineum Therapeutics, Inc. | 139,372 | reported | 01 Jun 2026 | tx 28+392,524−45,298 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 01 Jun 2026 | SALE | Contineum Therapeutics, Inc. | 4,170 | 13.16 USD | 10b5-1 |
| 02 Mar 2026 | SALE | Contineum Therapeutics, Inc. | 4,170 | 15.01 USD | |
| 24 Feb 2026 | EXERCISE | Contineum Therapeutics, Inc. | 4,300 | 1.01 USD | |
| 25 Feb 2026 | SALE | Contineum Therapeutics, Inc. | 3,824 | 16.01 USD | |
| 25 Feb 2026 | EXERCISE | Contineum Therapeutics, Inc. | 3,824 | 1.01 USD | |
| 24 Feb 2026 | SALE | Contineum Therapeutics, Inc. | 4,300 | 16.03 USD | |
| 24 Feb 2026 | EXERCISE | Contineum Therapeutics, Inc. | 4,300 | 0.00 USD | deriv |
| 25 Feb 2026 | EXERCISE | Contineum Therapeutics, Inc. | 3,824 | 0.00 USD | deriv |
| 19 Feb 2026 | SALE | Contineum Therapeutics, Inc. | 100 | 16.00 USD | |
| 19 Feb 2026 | EXERCISE | Contineum Therapeutics, Inc. | 100 | 1.01 USD | |
| 19 Feb 2026 | EXERCISE | Contineum Therapeutics, Inc. | 100 | 0.00 USD | deriv |
| 11 Feb 2026 | EXERCISE | Contineum Therapeutics, Inc. | 400 | 1.01 USD | |
| 11 Feb 2026 | SALE | Contineum Therapeutics, Inc. | 400 | 16.00 USD | |
| 11 Feb 2026 | EXERCISE | Contineum Therapeutics, Inc. | 400 | 0.00 USD | deriv |
| 03 Feb 2026 | SALE | Contineum Therapeutics, Inc. | 3,000 | 14.82 USD | |
| 03 Feb 2026 | SALE | Contineum Therapeutics, Inc. | 1,170 | 15.25 USD | |
| 30 Jan 2026 | GRANT_AWARD | Contineum Therapeutics, Inc. | 160,000 | 0.00 USD | deriv |
| 30 Jan 2026 | GRANT_AWARD | Contineum Therapeutics, Inc. | 6,500 | 0.00 USD | deriv |
| 05 Jan 2026 | SALE | Contineum Therapeutics, Inc. | 3,670 | 10.35 USD | |
| 05 Jan 2026 | SALE | Contineum Therapeutics, Inc. | 500 | 11.13 USD | |
| 23 Dec 2025 | SALE | Contineum Therapeutics, Inc. | 4,170 | 12.23 USD | |
| 31 Jan 2025 | GRANT_AWARD | Contineum Therapeutics, Inc. | 3,700 | 0.00 USD | deriv |
| 31 Jan 2025 | GRANT_AWARD | Contineum Therapeutics, Inc. | 110,000 | 0.00 USD | deriv |
| 25 Nov 2024 | SALE | Contineum Therapeutics, Inc. | 1,010 | 16.02 USD | |
| 18 Nov 2024 | SALE | Contineum Therapeutics, Inc. | 6,091 | 16.37 USD |